109 related articles for article (PubMed ID: 1857605)
1. [Importance of the detection of minimal residual disease in the management of acute leukemia].
Mód A; Tamáska J; Adám E; Gidáll J; Poros A; Király A; Natonek K; Pálóczi K; Hollán Z
Orv Hetil; 1991 Jun; 132(24):1291-6, 1299. PubMed ID: 1857605
[TBL] [Abstract][Full Text] [Related]
2. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
[TBL] [Abstract][Full Text] [Related]
3. [Bone marrow transplantation in the treatment of acute leukemias].
Moiseev SI; Ganapiev AA; Abdulkadyrov KM
Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052
[TBL] [Abstract][Full Text] [Related]
4. [Multidisciplinary diagnostics in acute leukemia].
Hokland P; Pedersen B; Bendix K; Koch JE; Pallisgaard N
Ugeskr Laeger; 1998 Sep; 160(38):5473-8. PubMed ID: 9763918
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
6. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
[TBL] [Abstract][Full Text] [Related]
7. [Detection of minimal residual disease in acute leukemias by flow cytometry].
Scolnik MP
Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance and prognostic detection of minimal residual disease in acute leukemias].
Deptała A; Widzyńska I; Kuratowska Z
Acta Haematol Pol; 1995; 26(4):413-20. PubMed ID: 8571743
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of response to intensive chemotherapy in acute leukaemic patients.
Mód A; Tamáska J; Poros A; Király A; Adám E; Gidáli J; Hollán SR
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():24. PubMed ID: 2627605
[No Abstract] [Full Text] [Related]
11. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
12. Significance of FCM-DNA measurement in detecting minimal residual disease in leukemia.
Zhang RX; Yao EG
Chin Med J (Engl); 1990 Oct; 103(10):826-30. PubMed ID: 2125256
[TBL] [Abstract][Full Text] [Related]
13. [The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].
Schattenberg AV; van de Wiel-van Kemenade E; Bär BM; Geurts van Kessel AH; van der Maazen RW; de Witte TJ
Ned Tijdschr Geneeskd; 1996 Oct; 140(42):2087-91. PubMed ID: 8965951
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
15. [Allogeneic bone marrow transplantation in a case of acute lymphoblastic leukemia with positive Philadelphia chromosome].
Kitoh T; Tabata Y; Akiyama Y; Kiriyama Y; Kubota M; Mikawa H
Rinsho Ketsueki; 1989 May; 30(5):680-5. PubMed ID: 2795882
[TBL] [Abstract][Full Text] [Related]
16. [Individualized treatment of leukemia patients by monitoring of minimal residual disease (MRD) based on WT1 assay].
Ogawa H; Sugiyama H
Rinsho Ketsueki; 1998 Feb; 39(2):107-8. PubMed ID: 9545812
[No Abstract] [Full Text] [Related]
17. [Bone marrow autotransplantation in patients with acute myeloblastic leukemia in primary remission].
Richard C; Iriondo A; Baro J; Conde E; Hermosa V; Alsar MJ; Gómez Casares MT; Muruzabal MJ; Pérez Encinas M; Zubizarreta A
Med Clin (Barc); 1990 Sep; 95(9):324-8. PubMed ID: 2280616
[TBL] [Abstract][Full Text] [Related]
18. Infant acute bilineal leukemia.
Derwich K; Sedek L; Meyer C; Pieczonka A; Dawidowska M; Gaworczyk A; Wachowiak J; Konatkowska B; Witt M; Marschalek R; Szczepański T
Leuk Res; 2009 Jul; 33(7):1005-8. PubMed ID: 19286255
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].
Tie LJ; Gu LJ; Song DL; Jiang LM; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Wang YP; Chen J
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):6-9. PubMed ID: 15946500
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]